These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6032479)

  • 1. Plasma levels of imipramine and desmethylimipramine during therapy.
    Moody JP; Tait AC; Todrick A
    Br J Psychiatry; 1967 Feb; 113(495):183-93. PubMed ID: 6032479
    [No Abstract]   [Full Text] [Related]  

  • 2. An explanatory statistical model for plasma levels of imipramine and desmethylimipramine during long-term therapy.
    Roberts CD; Roberts EN
    Br J Psychiatry; 1973 Jun; 122(571):736-7. PubMed ID: 4716078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J; Albin H; França X; Vinçon G; Démotes-Mainard F
    Ann Med Psychol (Paris); 1988; 146(8):764-72. PubMed ID: 3242402
    [No Abstract]   [Full Text] [Related]  

  • 4. Imipramine metabolites in blood of patients during therapy and after overdose.
    Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N
    Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New metabolites of imipramine.
    Crammer JL; Scott B
    Psychopharmacologia; 1966; 8(6):461-8. PubMed ID: 4162722
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.
    Nagy A; Treiber L
    J Pharm Pharmacol; 1973 Aug; 25(8):599-603. PubMed ID: 4148426
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and biliary excretion of the lipophilic drug molecules, imipramine and desmethylimipramine in the rat. I. Experiments in vivo and with isolated perfused livers.
    Bickel MH; Minder R
    Biochem Pharmacol; 1970 Aug; 19(8):2425-35. PubMed ID: 5520602
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic plasma-concentration range of imipramine against ventricular premature depolarizations.
    Giardina EG; Louie M; Bigger JT; Brem R; Alchevsky D
    Clin Pharmacol Ther; 1983 Sep; 34(3):284-9. PubMed ID: 6883904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
    Mavissakalian MR; Perel JM
    Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thin-layer chromatographic determination of imipramine and desipramine in human plasma and urine at single-dose levels.
    Sistovaris N; Dagrosa EE; Keller A
    J Chromatogr; 1983 Oct; 277():273-81. PubMed ID: 6643612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of imipramine and desipramine in human breast milk.
    Sovner R; Orsulak PJ
    Am J Psychiatry; 1979 Apr; 136(4A):451-2. PubMed ID: 426114
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between plasma and cerebrospinal levels of imipramine.
    Sathananthan GL; Gershon S; Almeida M; Spector N; Spector S
    Arch Gen Psychiatry; 1976 Sep; 33(9):1109-10. PubMed ID: 962493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for the determination of therapeutic levels of clomipramine, imipramine and desipramine.
    Howarth AT
    Postgrad Med J; 1977; 53 Suppl 4():131-5. PubMed ID: 600890
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel JM; Michelson L
    J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel J; Michelson L
    Psychopharmacol Bull; 1984; 20(1):123-5. PubMed ID: 6718637
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum imipramine concentrations lower than plasma values.
    Hullett FJ; Levy AB; Tachiki KH
    J Clin Psychiatry; 1984 Dec; 45(12):516-8. PubMed ID: 6501238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical pharmacology of imipramine. Implications for therapeutics.
    Glassman AH; Perel JM
    Arch Gen Psychiatry; 1973 May; 28(5):649-53. PubMed ID: 4573419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.